1水平测定及临床意义> SLE患者血清中MMP-9及TGF-β1水平测定及临床意义(3)
| 第1页 |
参见附件。
[5] Mawrin C,Brunn A,Rocken C,et al.Peripheral neuropathy in systemic lupus erythematosus:pathomorphological features and distribution pattern of matrix metalloproteinases[J].Acta Neuropathol,2003,105(4):365-372.
[6] Chang YH,Lin IL,Tsay GJ,et al.Elevated circulatory MMP-2 and MMP-9 levels and activities in patients with rheumatoid arthritis and systemic lupus erythematosus[J].Clin Biochem,2008,41(12):955-959.
[7] 刘暘，郑敏，殷文浩，等.血清基质金属蛋白酶-9检测与系统性红斑狼疮活动性的关系[J].中华风湿病学杂志,2004,8(4):220-222.
[8] Robak E,Wierzbowska A,Chmiela M,et al.Circulating total and active metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in patients with systemic lupus erythomatosus[J].Mediators Inflamm,2006,(1):17898.
[9] Kehrl JH,Thevenin C,Rieckmann P,et al.Transforming growth factor-beta suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA[J].J Immunol,1991,146(11):4016-4023.
[10] 姜有金，陈兴国，潘玉琴，等.SLE患者血中调节性T细胞及TGF-β1的表达[J].放射免疫学杂志,2010,23(6):605-608.
[11] 张江淮，陈伟，丁琼，等.系统性红斑狼疮患者血清TGF-β IFN-γ IL-10的检测及意义[J].安徽医学,2010,30(7):736-738.
[12] 孙保东，谭艳红，冯小欣，等.血清转化生长因子β1的表达在系统性红斑狼疮发病中的意义[J].临床和实验医学杂志,2006,5(7):906-907.
[13] 尹国才，郑毅，任建，等.自身免疫病患者血清TGF-β1的研究[J].中国免疫学杂志,1999,15(4):47.
[14] 庞久玲，刘爱东，刘军.转化生长因子β1和基质金属蛋白酶在病理性瘢痕中的表达及意义[J].实用医学杂志,2010,26(17):3175-3177.
(收稿日期：2011-08-25)
(本文编辑：郎威)
您现在查看是摘要介绍页，详见PDF附件。